Early Access — free while we kick the tires
Never miss a filing from General Atlantic (Al) Spv, LP
Watch this insider and we'll alert you the moment they file — at any company.
Activity
May 2026
1,975,000 shares
$32,929,750
General Atlantic Genpar bought 1.98M shares at $16.67 avg; stock -47.5% from 52-week high; 0 of 5 prior ALKT buys well-timed at 90d.
General Atlantic Genpar (Bermuda), LP, a Director, acquired 1,975,000 shares across three days (May 12–14, 2026) for $32,929,750.00 at a blended average price of $16.67. The current price of $16.62 sits -47.5% below the 52-week high of $31.66, indicating a substantial valuation decline. However, the insider's prior trade history at ALKT is concerning: 0 of 5 prior buys at this ticker were well-timed at the 90-day mark, suggesting a pattern of purchasing ahead of further weakness rather than near inflection points. The company remains unprofitable with negative net income, though it shows strong annual revenue growth of +32.9%, adding fundamental uncertainty to the timing signal.
2,066,543 shares
$34,664,924
General Atlantic Genpar (Bermuda) accumulates 2.07M ALKT shares across three days amid depressed valuation; fund's prior buys in this stock have struggled.
General Atlantic Genpar (Bermuda), a director and 10% beneficial owner, executed three substantial purchases of Alkami shares over consecutive trading days, accumulating more than 2 million shares while the stock trades significantly below its recent highs. This represents the fund's most aggressive buying sequence in Alkami to date, following a pattern of repeated acquisitions over the past year. However, the fund's track record with this specific stock is notably unfavorable—prior purchases in Alkami have consistently underperformed over the subsequent quarter, with the most recent buy in March showing substantial declines. The company itself remains unprofitable despite strong revenue growth, which means the fund is betting on a turnaround rather than a cash-generative business. General Atlantic's sustained buying at depressed levels suggests either conviction in a recovery narrative or portfolio rebalancing, but the repeated negative outcomes from prior purchases in this name creates tension between the fund's actions and its historical accuracy with Alkami specifically.
March 2026
500,000 shares
$9,165,000
General Atlantic director purchases 500,000 ALKT shares at $18.33; stock now $17.61 after cluster of three insider buys in 14 days
General Atlantic (BERMUDA), L.P. purchased 500,000 shares of Alkami at $18.33 on 2026-03-12, expanding holdings by +3.4% to 15.38M shares total. The purchase occurred as part of a cluster pattern: 2 other insiders also bought within the past 14 days, including purchases on 2026-03-11 and 2026-03-10 by the same entity. However, the broader context is mixed: stock is down 43.5% from its 52-week high of $31.19, trading at $17.61 (below the purchase price), and the company is unprofitable with net income of -$14.8M on latest quarterly revenue of $113.0M. At this ticker specifically, prior buys on 2025-08-13 produced 0 of 2 with positive 90-day returns, showing poor timing historically at Alkami.